Celltrion Receives Positive CHMP Opinion for Herzuma for Trastuzumab Biosimilar
Celltrion, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma®…
Read More...
Read More...
